Assessing the utility of three taqman probes for the diagnosis of tuberculosis and resistance to rifampin and isoniazid in veracruz, México

Canadian Journal of Microbiology

Volumn 58, Issue 3, 2012, Pages 318-325

  Zenteno Cuevas, Roberto ^a,b   Cuevas Cordoba, Betzaida ^a   Enciso, Antonio ^c   Enciso, Leonor ^c   Cuellar, Aremy ^d  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b Centro de Investigaciones Biomédicas en Enfermedades Infecciosas   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d Laboratorio Estatal Salud Publica de Los Servicios   (Mexico)

Author keywords

Isoniazid; Rifampin; TaqMan probes; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; MOLECULAR ANALYSIS; MUTATION; PROBE; RESPIRATION; TUBERCULOSIS;

ACID FAST BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA SEQUENCE; GENE MUTATION; HUMAN; KATG GENE; LUNG TUBERCULOSIS; MEXICO; MOLECULAR PROBE; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RPOB GENE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; GENETIC VARIATION; HUMANS; ISONIAZID; MEXICO; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MEXICO [NORTH AMERICA]; VERACRUZ;

BACILLI (CLASS);

EID: 84857809640     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/W11-127     Document Type: Article

References (29)

1. Abebe, G., Paasch, F., Apers, L., Rigouts, L., and Colebunders, R. 2011. Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. J. Microbiol. Methods, 84(2): 155-160. doi:10.1016/j.mimet.2010. 11.014. PMID:21129417.
2. Armand, S., Vanhuls, P., Delcroix, G., Courcol, R., and Lemaître, N. 2011. Comparison of the XpertMTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J. Clin. Microbiol. 49(5): 1772-1776.doi:10.1128/JCM.02157-10. PMID:21411592.
3. Brudey, K., Driscoll, J.R., Rigouts, L., Prodinger, W.M., Gori, A., Al- Hajoj, S.A., et al. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6(1): 23. doi:10.1186/1471-2180- 6-23. PMID:16448556.
4. Cockerill, F.R., III, Uhl, J.R., Temesgen, Z., Zhang, Y., Stockman, L., Roberts, G.D., et al. 1995. Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J. Infect. Dis. 171(1): 240-245. doi:10.1093/infdis/171.1.240. PMID:7798673.
5. Cuevas-Córdoba, B., and Zenteno-Cuevas, R. 2010. Drug resistant tuberculosis: molecular mechanisms and diagnostic methods. Enferm. Infecc. Microbiol. Clin. 28(9): 621-628. PMID: 20381927.[In Spanish.]
6. Driscoll, J.R. 2009. Spoligotyping for molecular epidemiology of the Mycobacterium tuberculosis complex. Methods Mol. Biol. 551: 117-128.PMID:19521871.
7. Espasa, M., González-Martín, J., Alcaide, F., Aragón, L.M., Lonca, J., Manterola, J.M., et al. 2005. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J. Antimicrob. Chemother. 55(6): 860-865. doi:10.1093/jac/ dki132. PMID:15879493.
8. García de Viedma, D. 2003. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin. Microbiol. Infect. 9(5): 349-359. doi:10.1046/ j.1469-0691.2003.00695.x. PMID:12848747.
9. García de Viedma, D., del Sol Díaz Infantes, M., Lasala, F., Chaves, F., Alcalá, L., and Bouza, E. 2002. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J. Clin. Microbiol. 40(3): 988-995. doi:10.1128/ JCM.40.3.988-995.2002. PMID:11880428.
10. Granich, R.M., Balandrano, S., Santaella, A.J., Binkin, N.J., Castro, K.G., Marquez-Fiol, A., et al. 2000. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. Arch. Intern. Med. 160(5): 639-644. doi:10.1001/archinte.160.5.639. PMID:10724049.
11. Helb, D., Jones, M., Story, C., Boehme, E., Wallace, E., Ho, K., et al. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48(1): 229-237. doi:10.1128/JCM.01463-09. PMID:19864480.
12. Kamerbeek, J., Schouls, L., Kolk, A., van Agterveld, M., van Soolingen, D., Kuijper, S., et al. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35(4): 907-914.PMID: 9157152.
13. Marín, M., García de Viedma, D., Ruíz-Serrano, M.J., and Bouza, E. 2004. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob. Agents Chemother. 48 (11): 4293-4300.doi:10.1128/AAC.48.11.4293-4300.2004. PMID:15504855.
14. Molina-Torres, C.A., Moreno-Torres, E., Ocampo-Candiani, J., Rendon, A., Blackwood, K., Kremer, K., et al. 2010. Mycobacterium tuberculosis spoligotypes in Monterrey, Mexico. J. Clin. Microbiol. 48(2): 448-455.doi:10.1128/JCM.01894-09. PMID:19940048.
15. Nava-Aguilera, E., López-Vidal, Y., Harris, E., Morales-Pérez, A., Mitchell, S., Flores-Moreno, M., et al. 2011. Clustering of Mycobacterium tuberculosis cases in Acapulco: spoligotyping and risk factors. Clin. Dev. Immunol. 2011. doi:10.1155/2011/ 408375. PMID:21197077.
16. Niemann, S., Köser, C.U., Gagneux, S., Plinke, C., Homolka, S., Bignell, H., et al. 2009. Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PLoS ONE, 4(10): e7407. doi:10.1371/journal.pone.0007407. PMID:19823582.
17. Palomino, J.C. 2009. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS. Immunol. Med. Microbiol. 56(2): 103-111.doi:10.1111/j.1574- 695X.2009.00555.x. PMID:19416361.
18. PAHO. 2004. Epidemiological tuberculosis situation (America's region 2004). Pan-American Health Organization. Available from http://www.paho.org/common/Display.asp?Lang=S&RecID = 6432 [accessed 15 February 2011].
19. Ramaswamy, S., and Musser, J.M. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79(1): 3-29.doi:10.1054/tuld. 1998.0002. PMID:10645439.
20. Telenti, A., Honore, N., Bernasconi, C., March, J., Ortega, A., Heym, B., et al. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35(3): 719-723.PMID:9041419.
21. Van Deun, A., Martin, A., and Palomino, J.C. 2010. Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int. J. Tuberc. Lung Dis. 14(2): 131-140. PMID:20074402.
22. van Doorn, H.R., Claas, E.C., Templeton, K.E., van der Zanden, A.G. M., te Koppele Vije, A., de Jong, M.D., et al. 2003. Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technologywith 30-minor groove binder-DNA probes. J. Clin. Microbiol. 41(10): 4630-4635.doi:10.1128/JCM.41.10.4630-4635.2003. PMID: 14532194.
23. Van Rie, A., Page-Shipp, L., Scott, L., Sanne, I., and Stevens, W. 2010. Xpert® MTB/RIF for point-of care diagnosis of TB in high- HIV burden, resource-limited countries: Hype or hope? Expert Rev. Mol. Diagn. 10(7): 937-946.doi:10.1586/erm.10.67. PMID: 20964612.
24. Wada, T., Maeda, S., Tamaru, A., Imai, S., Hase, A., and Kobayashi, K. 2004. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J. Clin. Microbiol. 42(11): 5277-5285.doi:10.1128/JCM.42.11.5277-5285.2004. PMID:15528726.
25. World Health Organization. 2008. Anti tuberculosis drug resistance in the world: fourth global report (WHO/HTM/TB/2008.394).
26. World Health Organization. 2010. Multidrug and extensively drugresistant TB (M/XDR-TB): 2010 global report on surveillance and response (WHO/HTM/TB/2010.3).
27. Zenteno-Cuevas, R., González, L., Cuellar, A., Parissi, A., and Fuentes, J. 2008. Detection of mycobacteria in respiratory samples by amplification of the marker rDNA16S by the polymerase chain reaction. Bioquimia, 33(1): 4-9.
28. Zenteno-Cuevas, R., Zenteno, J.C., Cuellar, A., Cuevas, B., Sampieri, C.L., Riviera, J.E., and Parissi, A. 2009. Mutations in rpoB and katG genes in Mycobacterium isolates from the southeast of Mexico. Mem. Inst. Oswaldo Cruz, 104(3): 468-472.doi:10.1590/ S0074-02762009000300012. PMID:19547874.
29. Zenteno-Cuevas, R., Rubí, A., Fuentes-Domínguez, J., Lara-González, J.L., and Escobar-Mesa, A. 2010. Dynamics of multidrug resistant tuberculosis in Veracruz, México between 2002 and 2008. J. Infect. Dev. Ctries. 4(11): 776-778. PMID:21252458.